- Home
- / EastWest Bioscience
EastWest Bioscience
Stock Price
$0
2023-05-08
Market Capitalization
$2.5 M
2023-05-08
Revenue
$1.1 M
FY, 2021
EastWest Bioscience Summary
Company Summary
- Overview
- EastWest Bioscience company is engaged in a multitude of brands in retail, manufacturing, supply chain, storage & distribution. It offers real estate properties and produces health supplements, vitamins, and consumer hemp products.
- Type
- Public
- Status
- Active
- Founded
- 2016
- Cybersecurity rating
Table of Contents
EastWest Bioscience Financials
Summary Financials
- Revenue (Q3, 2022)
- $C257.0K
- Gross profit (Q3, 2022)
- $C207.0K
- Net income (Q3, 2022)
- ($C561.0K)
- Cash (Q3, 2022)
- $C20.0K
- EBIT (Q3, 2022)
- $C8.0K
- Enterprise value
- $5.0M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026